Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET

Citations

WEB OF SCIENCE

25
Citations

SCOPUS

26

초록

Background: The standard Centiloid (CL) method was proposed to harmonize and quantify global F-18-labeled amyloid beta (A beta) PET ligands using MRI as an anatomical reference. However, there is need for harmonizing and quantifying regional A beta uptakes between ligands using CT as an anatomical reference. In the present study, we developed and validated a CT-based regional direct comparison of 18 F-florbetaben (FBB) and F-18-flutemetamol (FMM) Centiloid (rdcCL). Methods: For development of MRI-based or CT-based rdcCLs, the cohort consisted of 63 subjects (20 young controls (YC) and 18 old controls (OC), and 25 participants with Alzheimer's disease dementia (ADD)). We performed a direct comparison of the FMM-FBB rdcCL method using MRI and CT images to define a common target region and the six regional VOIs of frontal, temporal, parietal, posterior cingulate, occipital, and striatal regions. Global and regional rdcCL scales were compared between MRI-based and CT-based methods. For clinical validation, the cohort consisted of 2245 subjects (627 CN, 933 MCI, and 685 ADD). Results: Both MRI-based and CT-based rdcCL scales showed that FMM and FBB were highly correlated with each other, globally and regionally (R-2 = 0.96 similar to 0.99). Both FMM and FBB showed that CT-based rdcCL scales were highly correlated with MRI-based rdcCL scales (R-2 = 0.97 similar to 0.99). Regarding the absolute difference of rdcCLs between FMM and FBB, the CT-based method was not different from the MRI-based method, globally or regionally (p value = 0.07 similar to 0.95). In our clinical validation study, the global negative group showed that the regional positive subgroup had worse neuropsychological performance than the regional negative subgroup (p < 0.05). The global positive group also showed that the striatal positive subgroup had worse neuropsychological performance than the striatal negative subgroup (p < 0.05). Conclusions: Our findings suggest that it is feasible to convert regional FMM or FBB rdcSUVR values into rdcCL scales without additional MRI scans. This allows a more easily accessible method for researchers that can be applicable to a variety of different conditions.

키워드

Amyloid PET; CT; Regional modified Centiloid; Clinical validation; MRI
제목
Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET
저자
Kim, Soo-Jong; Ham, Hongki; Park, Yu Hyun; Choe, Yeong Sim; Kim, Young Ju; Jang, Hyemin; Na, Duk L.; Kim, Hee Jin; Moon, Seung Hwan; Seo, Sang Won
DOI
10.1186/s13195-022-01099-0
발행일
2022-10-20
유형
Article
저널명
Alzheimer's Research and Therapy
권
14
호
1